While the shift to cancer becoming more of a chronic disease does not have a huge change on the approach of the payer, there are some new challenges to address, said Jennifer Malin, MD, medical director for oncology at Anthem.
While innovations have made cancer more of a chronic disease, the shift does not change the approach of the payer too much, but there are some new challenges to address, said Jennifer Malin, MD, medical director for oncology at Anthem.
“We still look to figure out how we have access for our members to cancer care; we still look to provide care over the long term,” says Dr Malin.
However, she adds that it becomes more challenging to understand the data, where the gaps are and what the opportunities are when members transition to chronic care.
LLMs Show Promise, But Challenges Remain in Improving Inefficient Clinical Trial Screening
July 31st 2025Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of structured electronic health record data to capture all necessary criteria.
Read More